Sponsor

BeOne Medicines I GmbH

Aeschengraben 27, 4051

About the sponsor

BeOne Medicines I GmbH is active in advanced solid tumors, including metastatic and unresectable solid tumors, with research centered on new anticancer agents and combination strategies.

Advanced solid tumors
Metastatic solid tumors
Unresectable solid tumors
Antitumor activity

The sponsor’s oncology portfolio includes early clinical investigation of treatments intended for difficult-to-treat solid malignancies.

About Specializations

BeOne Medicines I GmbH runs clinical trials in conditions such as Hormone receptor positive HER2 negative breast cancer, B-cell small lymphocytic lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

2 clinical trials

Hormone receptor positive HER2 negative breast cancer

Recruiting

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo